UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
Back to Urology at UCLA home It Begins With U

Urology at UCLA

Print
Email
Share

Kiran Gollapudi, MD

Kiran Gollapudi, MD - Department of Urology

Kiran Gollapudi, MD UCLACONTACT INFORMATION:

  • Phone: (310) 206-8177
  • Fax: (310) 206-5343
  • Email:

BIO

Kiran Gollapudi was born in Washington DC, and grew up in Southern California.  He graduated magna cum laude with a B.A. in History from the University of California, Los Angeles.  He then stayed in Los Angeles and attended the David Geffen School of Medicine at UCLA where he was inducted into the AOA Honor Society.  During medical school, he spent a year at the National Institutes of Health as a Howard Hughes Medical Institute Research Scholar studying immunomodulatory properties and tissue engineering applications of bone marrow derived mesenchymal stem cells.  During his research year in residency he worked in the laboratory of Dr. William Aronson investigating the molecular mechanisms by which dietary fish oil supplementation decreases prostate cancer proliferation and the role of inflammation in prostate cancer progression.  He plans to pursue a fellowship in minimally invasive and robotic surgery.

EDUCATION

  • Doctor of Medicine, David Geffen School of Medicine at UCLA, 2008
  • Bachelor of Arts, History, magna cum laude, University of California, Los Angeles, 2003

HONORS AND AWARDS

  • Alpha Omega Alpha Medical Honor Society, David Geffen School of Medicine at UCLA, 2008
  • Howard Hughes Medical Institute/National Institutes of Health Research Scholar, 2006
  • Phi Beta Kappa, University of California Los Angeles, 2003

PUBLICATIONS

  • Gore JL, Gollapudi K, Bergman J, Kwan L, Krupski TL, Litwin MS. Correlates of bother following treatment for clinically localized prostate cancer. J Urol. 2010 Oct;184(4):1309-15
  • Janjanin S, Djouad F, Shanti RM, Baksh D, Gollapudi K, Prgomet D, Rackwitz L, Joshi AS, Tuan RS. Human palatine tonsil: a new potential source of multipotent mesenchymal progenitor cells. Arthritis Res Ther. 2008;10(4):R83.
  • Gollapudi K, Feeley BT, Otsuka NY. Advanced skeletal maturity in ambulatory cerebral palsy patients. J Pediatr Orthop. 2007;27(3):295-298.
  • Feeley BT, Gollapudi K, Otsuka NY . Body mass index in ambulatory cerebral palsy patients. J Pediatr Orthop B. 2007;16(3):165-9.
  • Gollapudi K, Krutzik SR, Sieling PA. Bacterial flagellin acts as a costimulatory signal for human T cell receptor activation. Journal of Investigative Medicine. 2005;(53):Abstract 297 S1230.

BOOK CHAPTERS

  • Li WJ, Gollapudi K, Patterson D, Huang G, Tuan RS. Cell based therapies for musculoskeletal repair. In: Principles of regenerative medicine. Eds: Atala A, Lanza R, Thomson J, Nerem R. Elsevier. 2008.

PRESENTATIONS

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases Seminar Series, Bethesda, MD (2007) “Human mesenchymal stem cell-based tissue-engineered cartilage constructs using cartilage powder and biodegradable nanofibers,” podium
  • American Academy of Orthopaedic Surgeons Annual Meeting, San Diego, CA (2007) “Advanced skeletal maturity in ambulatory cerebral palsy patients,” podium “Low body mass index in ambulatory cerebral palsy patients,” poster
  • American Academy of Pediatrics National Conference, Atlanta, GA (2006) “Advanced skeletal maturity in ambulatory cerebral palsy patients,” podium “Low body mass index in ambulatory cerebral palsy patients,” podium
  • Western Student Medical Research Forum, Carmel, CA (2005) “Bacterial flagellin acts as a costimulatory signal for human T cell activation,” podium
UCLA Rated One of the Top Hospitals in the Nation